摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-氨基-4-哌啶-1-苯甲酸 | 26586-27-6

中文名称
3-氨基-4-哌啶-1-苯甲酸
中文别名
——
英文名称
3-Amino-4-piperidino-benzoesaeure
英文别名
3-Amino-4-piperidin-1-yl-benzoic acid;3-amino-4-piperidin-1-ylbenzoic acid
3-氨基-4-哌啶-1-苯甲酸化学式
CAS
26586-27-6
化学式
C12H16N2O2
mdl
MFCD02225752
分子量
220.271
InChiKey
DFGNBCGBUAHIPC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    66.6
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    Xi
  • 海关编码:
    2933399090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-cyanofuran-2-carbonyl chloride3-氨基-4-哌啶-1-苯甲酸 在 PS-morpholine 作用下, 以 1,4-二氧六环 为溶剂, 反应 2.0h, 生成 3-(2-Cyanofuran-5-carboxamido)-4-(piperidin-1-yl)benzoic acid
    参考文献:
    名称:
    Potent 2′-aminoanilide inhibitors of cFMS as potential anti-inflammatory agents
    摘要:
    A series of 2 '-aminoanilides have been identified which exhibit potent and selective inhibitory activity against the cFMS tyrosine kinase. Initial SAR studies within this series are described which examine aroyl and amino group substitutions, as well as the introduction of hydrophilic substituents on the benzene core. Compound 47 inhibits the isolated enzyme (IC50 = 0.027 mu M) and blocks CSF-1-induced proliferation of bone marrow-derived macrophages (IC50 = 0.11 mu M) and as such, serves as a lead candidate for further optimization studies. (C) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.09.057
  • 作为产物:
    描述:
    3-硝基-4-哌啶-1-苯甲酸 在 palladium on activated charcoal 氢气溶剂黄146 作用下, 以 甲醇乙酸乙酯 为溶剂, 生成 3-氨基-4-哌啶-1-苯甲酸
    参考文献:
    名称:
    Potent 2′-aminoanilide inhibitors of cFMS as potential anti-inflammatory agents
    摘要:
    A series of 2 '-aminoanilides have been identified which exhibit potent and selective inhibitory activity against the cFMS tyrosine kinase. Initial SAR studies within this series are described which examine aroyl and amino group substitutions, as well as the introduction of hydrophilic substituents on the benzene core. Compound 47 inhibits the isolated enzyme (IC50 = 0.027 mu M) and blocks CSF-1-induced proliferation of bone marrow-derived macrophages (IC50 = 0.11 mu M) and as such, serves as a lead candidate for further optimization studies. (C) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.09.057
点击查看最新优质反应信息

文献信息

  • [EN] COMPOUNDS AND METHODS OF ACTIVATING LIPOPROTEIN LIPASE<br/>[FR] COMPOSÉS ET PROCÉDÉS D'ACTIVATION DE LIPOPROTÉINE LIPASE
    申请人:METREA BIOSCIENCES INC
    公开号:WO2022159445A1
    公开(公告)日:2022-07-28
    The present disclosure is generally directed to activators of lipoprotein lipase useful in the treatment of diseases and disorders modulated by said enzyme and having the Formula (I), or a pharmaceutically acceptable salt, isomer, solvate, prodrug, or tautomer thereof.
    本公开涉及的是脂蛋白脂酶激活剂,其具有公式(I)或其药学上可接受的盐、异构体、溶剂合物、前药或互变异构体,在治疗受该酶调节的疾病和疾病方面具有用途。
  • Potent 2′-aminoanilide inhibitors of cFMS as potential anti-inflammatory agents
    作者:Raymond J. Patch、Benjamin M. Brandt、Davoud Asgari、Nand Baindur、Naresh K. Chadha、Taxiarchis Georgiadis、Wing S. Cheung、Ioanna P. Petrounia、Robert R. Donatelli、Margery A. Chaikin、Mark R. Player
    DOI:10.1016/j.bmcl.2007.09.057
    日期:2007.11
    A series of 2 '-aminoanilides have been identified which exhibit potent and selective inhibitory activity against the cFMS tyrosine kinase. Initial SAR studies within this series are described which examine aroyl and amino group substitutions, as well as the introduction of hydrophilic substituents on the benzene core. Compound 47 inhibits the isolated enzyme (IC50 = 0.027 mu M) and blocks CSF-1-induced proliferation of bone marrow-derived macrophages (IC50 = 0.11 mu M) and as such, serves as a lead candidate for further optimization studies. (C) 2007 Elsevier Ltd. All rights reserved.
查看更多